Clinical trial

A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes

NCT00857558

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE2

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2017-03-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes, Type 2unresolved

Interventions

saxagliptinDRUG · verified · RxNorm: saxagliptin

placeboDRUG

Sponsors & collaborators

Kyowa Kirin Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00857558 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.